<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>de la Piedra</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Alcaraz</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Bellmunt</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Meseguer</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>GÃ³mez-Caamano</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ribal</surname>
    <given-names>MJ</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study</article-title>
  <source>Br J Cancer</source>
  <year>2013</year>
  <volume>108</volume>
  <issue>12</issue>
  <fpage>2565</fpage>
  <lpage>2572</lpage>
  <pub-id pub-id-type="doi">10.1038/bjc.2013.270</pub-id>
  <pub-id pub-id-type="pmid">23722472</pub-id>
 </element-citation>
</ref>
